NanoBio Lab is proud to announce that Prof. Jackie Y. Ying is this year’s recipient of the Journal of Drug Targeting’s Lifetime Achievement Award. Each year since 2004, a scientific panel comprising members of the editorial board and representatives from the publisher, Taylor and Francis/Informa PLC, will select an outstanding researcher working on drug delivery and targeting for this honor.

Prof. Ying was recognized for her many outstanding and sustained contributions to the fields of nanotechnology and nanomedicine, including drug delivery and targeting. Among her numerous accomplishments in these fields are the development of an auto-regulated insulin delivery technology that responses to blood glucose levels, a Dengue test kit that was named one of Singapore’s top 50 Innovations for 1965-2015, as well as rapid diagnostic assays for infectious diseases, including COVID-19.

“I would like to dedicate this award to my staff at the NanoBio Lab, my students at MIT, as well as collaborators at Khoo Teck Puat Hospital, National University Hospital, Tan Tock Seng Hospital, Singapore General Hospital, and KK Women’s and Children’s Hospital. We have been focused on innovations that have the potential to improve diagnosis and treatment of diseases. Such technologies require not only R&D breakthroughs, but also significant efforts in clinical validation and successful commercialization to realize the impact on healthcare. I am blessed to be working with an excellent team of scientists and clinicians who share a common vision and drive towards advancing medical technologies and making them more accessible,” said Prof. Ying.

This award also recognizes Prof. Ying’s achievements in translational research, mentorship, and service to her profession. Clarivate Analytics recognized Prof. Ying as a Highly Cited Researcher in the Cross-Field Category. She has over 190 primary patents filed/granted, and has licensed 39 of them to multinational companies and start-ups for diverse applications including nanomedicine, drug delivery, medical implants, cell and tissue engineering, bioassays and medical devices. Prof. Ying oversaw the training and mentoring of over 120 Ph.D. students and over 2,864 research internship students at the Institute of Bioengineering and Nanotechnology (2003-2018) and NanoBio Lab (2018- 2020).

The Journal of Drug Targeting dedicated a special issue in honor of Prof. Ying by featuring articles that reflect the multidisciplinary nature of her research. Along with a print copy of this issue, Prof. Ying will also receive a commemorative plaque for the Lifetime Achievement Award.

Read more here.